Testing effectiveness (Phase 2)Looking for participantsNCT07381075
What this trial is testing
A Phase II Clinical Trial of Anti-EGFR Antibody-drug Conjugate (ADC) Combined With or Without Immune Checkpoint Inhibitors in the Neoadjuvant Treatment of Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
Who this might be right for
Head and Neck Squamous Cell Carcinoma
West China Hospital 90